BA
The Boeing Company
BA has the edge over NPK overall, supported by stronger valuation and stronger fundamentals.
NPK
National Presto Industries, Inc.
NPK trails on the overall score without a compensating advantage in the available component scores.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
NPK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
NPK's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over NPK in the historical PE scenario, which offers more potential upside but is not a forecast.
NPK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $85.32 | -39% |
| Fair | 19x | $112 | -20% |
| Current | 23x | $140 | — |
| Expensive | 24x | $146 | +4.2% |
Historical ranges are pointers, not guarantees.
NPK's PE is in its expensive range at 23x.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
NPK Forward outlook
There aren't enough analyst estimates for NPK to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
NPK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.98 | +2.4% |
| Q1 2026 | $4.49 | -25% |
| Q4 2025 | $4.63 | -20% |
| Q3 2025 | $5.45 | +15% |
| Q2 2025 | $5.84 | +27% |
| Q1 2025 | $5.97 | +32% |
| Q4 2024 | $5.82 | +20% |
| Q3 2024 | $4.75 | +43% |
NPK has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
NPK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $146.6M | +22% |
| Q1 2026 | $118.6M | +14% |
| Q4 2025 | $164M | +22% |
| Q3 2025 | $115.5M | +26% |
| Q2 2025 | $120.4M | +42% |
| Q1 2025 | $103.6M | +35% |
| Q4 2024 | $134.7M | +37% |
| Q3 2024 | $91.8M | +10% |
NPK has the edge over BA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | +8.2 points |
| Q1 2026 | 6.8% | -2 points |
| Q4 2025 | 11% | -6 points |
| Q3 2025 | 5.5% | -4.5 points |
| Q2 2025 | 5.1% | -2.4 points |
| Q1 2025 | 8.8% | +0.6 points |
| Q4 2024 | 17% | +3.8 points |
| Q3 2024 | 10% | +1.5 points |
NPK has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over NPK on cash flow, with more consistent year-over-year improvement.
NPK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $9.3M | +$22.7M |
| Q1 2026 | $29.4M | +$39.9M |
| Q4 2025 | $12.4M | +$23.7M |
| Q3 2025 | -$24.7M | -$4.4M |
| Q2 2025 | -$13.4M | +$21.3M |
| Q1 2025 | -$10.5M | -304% |
| Q4 2024 | -$11.3M | -169% |
| Q3 2024 | -$20.3M | -$15.2M |
NPK's free cash flow has turned positive after three years mostly in the red: $26M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
NPK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +39K shares |
| 1 year | +0.9% | +66K shares |
| 3 years | +1.5% | +108K shares |
NPK has the edge over BA on shareholder dilution, with a more favorable share count trend.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
NPK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
NPK has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
NPK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 49.6 | Neutral |
NPK's weekly RSI is 50 (neutral) and its Stochastic is 50 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over NPK on valuation relative to its sector.
NPK PE vs Industrials Sector
| Metric | NPK | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 2.5% below |
| PE % | 76 | 58 | 18 pts above |
NPK is trading at 23x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
NPK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $147.0 | 4.5% below |
| 20 week MA | $141.1 | 0.6% below |
| 50 week MA | $133.0 | 5.5% above |
| 100 week MA | $115.5 | 22% above |
| 200 week MA | $95.9 | 46% above |
NPK has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
NPK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $89.0 | $87.8 | -1.3% |
| 2021 | $87.8 | $82.2 | -6.4% |
| 2022 | $82.2 | $69.1 | -16% |
| 2023 | $69.1 | $80.3 | +16% |
| 2024 | $80.3 | $97.2 | +21% |
| 2025 | $97.2 | $108.5 | +12% |
| 2026 YTD | $108.5 | $140.3 | +29% |
NPK has the edge over BA on returns for 2026, with the stronger performance.